EUVIMEDEUVIMED entdecken
Crossref

Microfluidic Controllable Preparation of Iodine‐131‐Labeled Microspheres for Radioembolization Therapy of Liver Tumors

Qing-Rong Jiang, Xing-Qun Pu, Chuan-Fu Deng, Wei Wang, Zhuang Liu, Rui Xie, Da-Wei Pan, Wen-Jie Zhang, Xiao-Jie Ju iD, Liang-Yin Chu

Advanced Healthcare Materials · 2023-08 · 12 (21)

DOI: 10.1002/adhm.202300873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 12.07.2023. Verfasst von Qing-Rong Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, Sichuan University, Chengdu, 610065, P. R. China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcatheter arterial radioembolization (TARE) is of great significance for the treatment of advanced hepatocellular carcinoma (HCC). However, the existing radioembolic microspheres still have problems such as non‐degradability, non‐uniform size, and inability to directly monitor in vivo, which hinders the development of TARE. In this paper, a novel radioembolic agent, 131 I‐labeled methacrylated gelatin microspheres ( 131 I‐GMs), is prepared for the treatment of HCC. Water‐in‐oil (W/O) emulsion templates are prepared by a simple one‐step microfluidic method to obtain methacrylated gelatin microspheres (GMs) after UV irradiation. A series of GMs with uniform and controllable size is obtained by adjusting the flow rate of each fluid. Both air‐dried and freeze‐dried GMs can quickly restore their original shape and size, and still have good monodispersity, elasticity, and biocompatibility. The radiolabeling experiments show that 131 I can efficiently bind to GMs by chloramine‐T method, and the obtained 131 I‐GMs have good radioactive stability in vitro. The results of in vivo TARE treatment in rats show that 131 I‐GMs can be well retained in the hepatic artery and have a good inhibitory effect on the progression of liver cancer, showing the potential for the treatment of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularRatsAnimalsMicrospheresGelatinMicrofluidicsIodine Radioisotopes

Stichwörter der Autor:innen

Iodine-131hepatocellular carcinomamethacrylated gelatinmicrofluidicstranscatheter arterial radioembolization

Substanzen

GelatinIodine-131Iodine Radioisotopes

Autor:innen und Institutionen

  • School of Chemical Engineering, Sichuan University, Chengdu, 610065, P. R. China.
  • Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China.

ORCID-Profile: Xiao-Jie Ju

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Jiang, Q. R., Pu, X. Q., Deng, C. F., Wang, W., Liu, Z., Xie, R., Pan, D. W., Zhang, W. J., Ju, X. J., & Chu, L. Y. (2023). Microfluidic Controllable Preparation of Iodine‐131‐Labeled Microspheres for Radioembolization Therapy of Liver Tumors. Advanced Healthcare Materials, 12(21). https://doi.org/10.1002/adhm.202300873

Vancouver

Jiang QR, Pu XQ, Deng CF, Wang W, Liu Z, Xie R, et al. Microfluidic Controllable Preparation of Iodine‐131‐Labeled Microspheres for Radioembolization Therapy of Liver Tumors. Advanced Healthcare Materials. 2023;12(21). doi:10.1002/adhm.202300873

BibTeX
@article{Jiang2023,
  author = {Jiang, Qing-Rong and Pu, Xing-Qun and Deng, Chuan-Fu and Wang, Wei and Liu, Zhuang and Xie, Rui and Pan, Da-Wei and Zhang, Wen-Jie and Ju, Xiao-Jie and Chu, Liang-Yin},
  title = {Microfluidic Controllable Preparation of Iodine‐131‐Labeled Microspheres for Radioembolization Therapy of Liver Tumors},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  volume = {12},
  number = {21},
  doi = {10.1002/adhm.202300873}
}
Kostenlos starten →